• Bring Clarity to a Complex Disease
  • Advanced technologies to better characterize and assess cancer
GE Healthcare Biopharma Services

Pharma Services

GE Healthcare BioPharma Services provides expert product development support from discovery through product launch, including research services, biomarker discovery, assay development, clinical trial testing solutions, next generation sequencing, and data analytics.

Learn more 

PATHSiTE™ Virtual HemeFISH

Innovation Powered by Simplicity

PATHSiTE Virtual HemeFISH (VHF)  is the latest innovation in digital pathology services. VHF can help you better interpret, diagnose and report on suspected blood cancers and disorders.

Learn more 

Now Available


Ventana ALK (D5F3) CDx IHC assay (FDA-Approved)

Indicated as an aid in identifying patients eligible for treatment with XALKORI® (crizotinib).


Learn more



Now available! PD-L1, 22C3 FDA approved

PharmDx, approved PD-L1 companion diagnostic for Merck’s Keytruda®

Precise Diagnosis for Precision Lung Cancer Drug

GE Healthcare Press Release  |   Editorial  |   Video Dr. Ken Bloom
Learn more | Merck Keytruda Press Release

All clinical laboratory services described in this website are provided by Clarient Diagnostic Services, Inc., a clinical laboratory licensed under the Clinical Laboratory Improvement Amendment of 1988 ("CLIA").
Clarient Diagnostic Services, Inc. is a wholly owned subsidiary of General Electric Company.